EBITDA for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current EBITDA (TTM) is $12.89B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$12.89B
YoY change
+144.0%
5Y CAGR
+21.2%
Peak year (2015)
$23.45B
Cumulative EBITDA
$172.80B
EBITDA history chart for Gilead Sciences (GILD) from 1990 to 2025
EBITDA history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $10.82B | +144.0% | ||
| 2024 | $4.43B | -57.8% | ||
| 2023 | $10.50B | +18.6% | ||
| 2022 | $8.85B | -21.9% | ||
| 2021 | $11.33B | +174.1% | ||
| 2020 | $4.13B | -45.3% | ||
| 2019 | $7.56B | -26.6% | ||
| 2018 | $10.30B | -35.3% | ||
| 2017 | $15.93B | -17.1% | ||
| 2016 | $19.22B | -18.0% | ||
| 2015 | $23.45B | +43.7% | ||
| 2014 | $16.32B | +235.8% | ||
| 2013 | $4.86B | +14.3% | ||
| 2012 | $4.25B | +2.2% | ||
| 2011 | $4.16B | -3.0% | ||
| 2010 | $4.29B | +13.3% | ||
| 2009 | $3.78B | +30.8% | ||
| 2008 | $2.89B | +30.6% | ||
| 2007 | $2.22B | +31.7% | ||
| 2006 | $1.68B | +47.0% | ||
| 2005 | $1.14B | +75.6% | ||
| 2004 | $651.79M | +85.8% | ||
| 2003 | $350.78M | +267.6% | ||
| 2002 | $95.44M | -190.0% | ||
| 2001 | -$106.00M | +163.0% | ||
| 2000 | -$40.31M | +3.1% | ||
| 1999 | -$39.10M | -39.9% | ||
| 1998 | -$65.10M | +14.4% | ||
| 1997 | -$56.90M | +80.1% | ||
| 1996 | -$31.60M | +9.7% | ||
| 1995 | -$28.80M | -8.0% | ||
| 1994 | -$31.30M | — | ||
| 1992 | -$16.50M | +211.3% | ||
| 1991 | -$5.30M | +32.5% | ||
| 1990 | -$4.00M | — |
EBITDA values are taken from Gilead Sciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Gilead Sciences (GILD) most recent annual EBITDA stands at $10.82B (2025) – surged 144.0% year-over-year.
Across 2020–2025 (5 years), Gilead Sciences EBITDA produced a CAGR of +21.2% – with the latest reading among the more recent periods of the dataset.
Gilead Sciences EBITDA peaked at $23.45B in 2015; the latest annual figure is $10.82B in 2025 (53.8% below peak).
2015 marks the peak EBITDA at $23.45B, with the historical low of -$106.00M recorded in 2001.
Within Healthcare, Gilead Sciences (GILD) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
Gilead Sciences EBITDA by Year
Gilead Sciences EBITDA 2025: $10.82B
Gilead Sciences EBITDA in 2025 was $10.82B, surged 144.0% from 2024.
Gilead Sciences EBITDA 2024: $4.43B
Gilead Sciences EBITDA in 2024 was $4.43B, plunged 57.8% below 2023.
Gilead Sciences EBITDA 2023: $10.50B
Gilead Sciences EBITDA in 2023 was $10.50B, grew 18.6% from 2022.
Gilead Sciences EBITDA 2022: $8.85B
Gilead Sciences EBITDA in 2022 was $8.85B, declined 21.9% below 2021.
Gilead Sciences EBITDA 2021: $11.33B
Gilead Sciences EBITDA in 2021 was $11.33B.
See more financial history for Gilead Sciences (GILD).
Sector peers — EBITDA
Companies in the same sector as Gilead Sciences, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Gilead Sciences's EBITDA?
- Latest reported EBITDA for Gilead Sciences (GILD) is $12.89B (period ending December 31, 2025).
How has Gilead Sciences EBITDA changed year-over-year?
- Gilead Sciences (GILD) EBITDA changed +144.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences EBITDA?
- Gilead Sciences (GILD) EBITDA compound annual growth rate is +21.2% over the most recent 5 years available.
When did Gilead Sciences EBITDA hit its highest annual value?
- Gilead Sciences EBITDA reached its highest annual value of $23.45B in 2015.
What was Gilead Sciences EBITDA in 2024?
- Gilead Sciences (GILD) EBITDA in 2024 was $4.43B.
What was Gilead Sciences EBITDA in 2025?
- Gilead Sciences (GILD) EBITDA in 2025 was $10.82B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.